아이엠바이오로직스

493280KOSDAQ

42.0 / 100

Reference Date: 2026-10-23

Financial Score16.5 / 40

News Sentiment12.5 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 9.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Number of Employees

41people

Average Salary

76.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

112.11Industry Average 15.000.0Point

7.5x industry avg (risky)

PBR

2.90Industry Average 1.200.0Point

2.4x industry avg (risky)

ROE

—Industry Average 8.003.5Point

Debt Ratio

1.09Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 5.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

2.0 / 4

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 14,350Won52-week high 104,00052-week low 13,800

1-month return1.0Point

1m -9.81% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral기업설명회(IR)개최2026-10-19